Cornu G - Search Results

1

Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction.

Nizet Y, Van Daele S, Lewalle P, Vaerman JL, Philippe M, Vermylen C, Cornu G, Ferrant A, Michaux JL, Martiat P. Nizet Y, et al. Among authors: cornu g. Blood. 1993 Sep 1;82(5):1618-25. Blood. 1993. PMID: 8364210 Free article.

2

Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome.

Nizet Y, Martiat P, Vaerman JL, Philippe M, Wildmann C, Staelens JP, Cornu G, Ferrant A, Michaux JL, Sokal G. Nizet Y, et al. Among authors: cornu g. Br J Haematol. 1991 Oct;79(2):205-10. doi: 10.1111/j.1365-2141.1991.tb04523.x. Br J Haematol. 1991. PMID: 1958477

3

High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis.

Gala JL, Vermylen C, Cornu G, Ferrant A, Michaux JL, Philippe M, Martiat P. Gala JL, et al. Among authors: cornu g. Ann Hematol. 1994 Jul;69(1):17-24. doi: 10.1007/BF01757343. Ann Hematol. 1994. PMID: 8061103

4

Bone marrow transplantation in sickle cell anaemia.

Vermylen C, Cornu G. Vermylen C, et al. Among authors: cornu g. Blood Rev. 1993 Mar;7(1):1-3. doi: 10.1016/0268-960x(93)90017-x. Blood Rev. 1993. PMID: 8467226

5

A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse.

Jacquy C, Delepaut B, Van Daele S, Vaerman JL, Zenebergh A, Brichard B, Vermylen C, Cornu G, Martiat P. Jacquy C, et al. Among authors: cornu g. Br J Haematol. 1997 Jul;98(1):140-6. doi: 10.1046/j.1365-2141.1997.1792996.x. Br J Haematol. 1997. PMID: 9233577 Free article.

6

Differentiation of acute myeloid leukemia from B- and T-lineage acute lymphoid leukemias by real-time quantitative reverse transcription-PCR of lineage marker mRNAs.

Saussoy P, Vaerman JL, Straetmans N, Deneys V, Cornu G, Ferrant A, Latinne D. Saussoy P, et al. Among authors: cornu g. Clin Chem. 2004 Jul;50(7):1165-73. doi: 10.1373/clinchem.2003.030114. Clin Chem. 2004. PMID: 15229149

7

Expression of lineage markers using real-time quantitative polymerase chain reaction (RT-qPCR) in normal and in leukemia bone marrow.

Saussoy P, Vaerman JL, Druez V, Deneys V, Straetmans N, Cornu G, Ferrant A, Latinne D. Saussoy P, et al. Among authors: cornu g. Clin Chem Lab Med. 2009;47(4):419-26. doi: 10.1515/CCLM.2009.093. Clin Chem Lab Med. 2009. PMID: 19327122

8

Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remission.

Ferrant A, Doyen C, Delannoy A, Cornu G, Martiat P, Latinne D, De Bruyère M, Bosly A, Michaux JL, Sokal G. Ferrant A, et al. Among authors: cornu g. Bone Marrow Transplant. 1991 Apr;7(4):303-9. Bone Marrow Transplant. 1991. PMID: 2070137

9

Bone marrow transplantation for sickle cell disease. The European experience.

Vermylen C, Cornu G. Vermylen C, et al. Among authors: cornu g. Am J Pediatr Hematol Oncol. 1994 Feb;16(1):18-21. Am J Pediatr Hematol Oncol. 1994. PMID: 8311167

10

Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial.

Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Devalck C, Fondu P, Toppet M, Sariban E. Ferster A, et al. Among authors: cornu g. Blood. 1996 Sep 15;88(6):1960-4. Blood. 1996. PMID: 8822914 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters